Metastatic BRCA Hereditary Breast Carcinoma
2 clinical trials · Condition
◉ Watch Metastatic BRCA Hereditary Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer (NCT04673448) | University of Washington | 2021-10-18 |
| Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases (NCT02595905) | National Cancer Institute (NCI) | 2016-09-15 |
Track Metastatic BRCA Hereditary Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.